4th International Conference on Hypertension & Healthcare September 10-12, 2018 Zurich, Switzerland

Thời gian:

Thứ hai, Tháng 9 10, 2018 - 07:00 to Thứ tư, Tháng 9 12, 2018 - 17:00

About Conference

We take the privilege of hosting International Hypertension meetings worldwide and very excited to expand to Europe. Previous meetings Hypertension 2016 was held in Toronto, Canada and Hypertension 2017 was held in Amsterdam, Netherlands. With the valuable support of Organizing Committee Members, 4th International Conference on Hypertension & Healthcare planned to be held in the beautiful Zurich City, Switzerland which is small but well know country in the heart of Europe during September 10-12, 2018.

Working under the theme “Control Hypertension: Add life to Longevity” we bring together a unique international mix of large and medium medical and clinical research and diagnostic companies, leading universities and medical research institutions. This is a perfect platform to share experience, foster collaborations across industry and academia and evaluate emerging innovations around the world. This conference mainly focuses on spreading the awareness about challenges in this field and how to prevent and manage hypertension and other cardiovascular diseases.

Conference Series LLC through its Open Access Initiative is committed to create real and reliable contributions to the scientific community. Conference Series Ltd organize 600+ Conferences once a year across USA, Europe & Asia with support from a thousand additional scientific societies and Publishes 400+ Open access journals that contains over 30000 eminent personalities, putative scientists as editorial board members.

Why to attend??

Encounter the target market with members from across the globe, committed to learn about hypertension treatment and management. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the current situation of hypertension treatment and receive name recognition at this 3-days event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Hypertension Management are the principal features of this conference.

Target Audience:

Our Organization would be privileged to welcome the:

Directors of Hypertension or related Programs or Associations
Heads, Deans and Professors of Hypertension or Cardiology departments
Scientists and Researchers organizers
Doctors
Medical Colleges
Writers
Healthcare professionals
Founders and Employees of the related companies
Clinical investigators
Hospitals and Health Services
Pharmaceutical companies
Laboratory members
Training institutions
Support organizers
Data Management Companies
Cardiologists training and education
Nurse and nursing education institutions

Sessions

Encouraged with the success of hypertension conference series, we bring up the 4th International Conference on Hypertension and Healthcare with its powerful 3-days agenda. Hypertension 2018 is designed to take place at the beautiful Zurich in the Switzerland during September 10-12, 2018.

Track 1: Hypertension

Hypertension, additionally called as high vital sign or blood vessel cardiovascular disease could be a chronic medical condition during which the blood pressure within the arteries is elevated. This session mainly covers the different types of hypertension and their assessment. Isolated systolic hypertension, resistant hypertension are all recognized hypertension sorts with specific diagnostic criteria. A sphygmomanometer, is a device used to measure blood pressure, composed of an inflatable cuff to collapse and then release the artery under the cuff in a controlled manner, and a mercury.

Globally, the overall prevalence of raised blood pressure in adults aged 25 and over was around 40% in 2010. Because of population growth and ageing, the number of people with uncontrolled hypertension ranges from 600 million in 1980 to nearly 1 billion in 2010.The national Million Hearts initiative endeavors to increase the number of persons whose hypertension is under control, by 10 million, as part of its goal to prevent 1 million heart attacks and strokes by the year of 2018.

Secondary hypertension
Hypertension rheumatoid arthritis
Pediatric hypertension
Oncology and blood pressure
Genetic factors and life style of high blood pressure
Hypertension and obesity

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 2: High Blood Pressure and kidney Diseases

Renovascular hypertension (RVHT) reflects the causal relation between anatomically evident arterial occlusive disease and elevated blood pressure. The coexistence of renal arterial vascular disease and hypertension roughly defines this type of nonessential hypertension. More specific diagnoses are made retrospectively when hypertension improves after intravascular intervention. At present, no sufficiently accurate, noninvasive, radiologic, or serologic screening test is available that, if negative, completely excludes the presence of renal artery stenosis (RAS).

This category includes the following sub topics: kidney failure, nephrotoxicity, Iga nephropathy, Alport syndrome, minimal change disease, kidney and anemia, inherited kidney diseases, medullary sponge kidney, advances in nephrology, renal histopathology, kidney stones, nephronophthisis, nephroptotic, clinical nephrology-general aspects, infection and renal disease.

Renal disease
Assessment for reno vascular hypertension
Prevalence of epidemiology
Kidney transplantation
Nephrology therapies
Evidence based methodologies for renal diagnosis and management
Clinical administration abilities
Hereditary factors and endocrine issue
Care of dialysis and transplantation

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 3: Pulmonary Hypertension

Pulmonary hypertension (PH) is a rise of blood pressure within the artery, vein, or respiratory organ capillaries, resulting in shortness of breath, dizziness, fainting, leg swelling and different symptoms. This type of hypertension that affects the arteries in the lungs and the right side of your heart, then it begins when tiny arteries in your lungs, called pulmonary arteries, and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through your lungs, and raises pressure within your lungs' arteries.

As the pressure builds, your heart's lower right chamber must work harder to pump blood through your lungs, eventually causing your cardiac muscle to weaken and eventually fail. Pulmonary hypertension is a serious illness that becomes progressively worse and is sometimes fatal. Pulmonary hypertension worsens over time and is life-threatening because the pressure in a patient's pulmonary arteries rises to dangerously high levels, putting a strain on the heart. There is no cure for pulmonary hypertension, but several medications are available to treat symptoms. The various complications to related to pulmonary hypertension are congestive heart failure, blood clotting, liver disease, Lupus, Rheumatoid Arthritis, chronic bronchitis, HIV Associated Pulmonary Hypertension, and PH in Association with Sickle Cell Disease.

Classification of pulmonary hypertension
Sign, symptoms and causes of PH
Genetics and molecular pathology
Pulmonary embolism
Diagnosis by echocardiography
Treatment and therapies.
Asthma and allergy
Prevalence of pulmonary hypertension

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 4: Gestational Hypertension

Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of new hypertension in a pregnant woman after 20 weeks’ gestation without the presence of protein in the urine or other signs of preeclampsia and eclampsia. Gestational hypertension is usually defined as having a blood pressure higher than 140/90 measured on two separate occasions, more than 6 hours apart, without the presence of protein in the urine and diagnosed after 20 weeks of gestation. There is no specific treatment, but is monitored closely to rapidly identify pre-eclampsia and its life-threatening complications.

Drug treatment options are limited, as many antihypertensive may negatively affect the fetus. Methyldopa, hydralazine, and labetalol are most commonly used for severe pregnancy hypertension. The fetus is at increased risk for a variety of life-threatening conditions, including pulmonary hypoplasia (immature lungs). If the dangerous complications appear after the fetus has reached a point of viability, even though still immature, then an early delivery may be warranted to save the lives of both mother and baby. An appropriate plan for labor and delivery includes selection of a hospital with provisions for advanced life support of newborn babies.

During gestational hypertension, a woman must be offered an integrated package of care, covering admission to hospital, treatment, measurement of blood pressure, testing for proteinuria and blood tests.

Gestational hypertension in a future pregnancy ranges from about 1 in 8 (13%) pregnancies to about 1 in 2 (53%) pregnancies.

Risk factors for Gestational Hypertension
Pre-eclampsia and eclampsia
Pathogenesis of pre-eclampsia
Genetic changes and stress incontinence.
Surgical and non-surgical conditions
Restorative and administration of medications
Drug treatment of gestational hypertension

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 5: Hypertension & Stroke

Hypertension is the most prevalent and powerful modifiable risk factor for stroke. Persons with hypertension are about 3 or 4 times more likely to have a stroke. Hypertension remains the single most important modifiable risk factor for stroke, and the impact of hypertension and nine other risk factors together account for 90% of all strokes. The two major types of stroke include ischemic stroke (caused by blood clots), which accounts for 85% of strokes, and hemorrhagic stroke (bleeding in the brain), which accounts for 15% of strokes.

Prevention of stroke is a major public health priority, but needs to be based on a clear understanding of the key preventable causes of stroke. Therefore, although the highest BP levels predict the highest relative risk of stroke, the conceptual pendulum has swung in the direction of the continuum of absolute BP levels and somewhat away from the construct of “hypertension”. Furthermore, as discussed below, recent evidence points to the fact that mediators of hypertension, such as Angiotensin II, may influence stroke risk independently of Blood pressure elevation.

Idiopathic intracranial hypertension
Brain RAS on blood pressure control
Hypertensive encephalopathy
Cerebrovascular dysfunction
Stroke epidemiology and prevention
Hemorrhagic stroke
Myocardial infarction

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 6: Hypertension and Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period. Serious long-term complications include cardiovascular disease, stroke, chronic kidney failure, foot ulcers, and damage to the eyes.

Hypertension and diabetes are two of the leading risk factors for atherosclerosis and its complications, including heart attacks and strokes. There is substantial overlap between diabetes and hypertension, reflecting substantial overlap in their etiology and disease mechanisms. Cardiovascular risk factor prevalence study, only 42% of people with diabetes had normal blood pressure and only 56% of people with hypertension had normal glucose tolerance.

Diabetes causes hyperinsulinemia and raises the risk of hypertension. This condition increases the amount of sodium that the body absorbs. It also promotes the stimulation of the sympathetic nervous system. This is thought to cause changes in blood vessel structure, which affects the function of the heart and blood pressure.

Risk factors for diabetes
Treatment and therapies.
Diabetes and dermatology
Destruction of the islet β-cell
Advanced treatments for diabetes
Herbal and alternative remedies
Early management of obesity

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 7: Hypertensive Heart Disease

Heart disease describes a range of conditions that affect the heart. Diseases under the heart includes blood vessel diseases, such as coronary artery disease; heart rhythm problems (arrhythmias); and heart defects you're born with (congenital heart defects), among others. Heart disease term is often used interchangeably with the cardiovascular disease. It generally refers to conditions that involve narrowed or blocked blood vessels that can lead to a heart attack, chest pain (angina) or stroke. Other heart conditions, such as those that affect your heart's muscle, valves or rhythm, also are considered forms of heart disease. Many forms of heart disease can be prevented or treated with healthy lifestyle choices.

Heart disease is the study of the effects of drugs on the entire cardiovascular system, which includes the heart and blood vessels. The various complications to related to diabetes are Cerebrovascular disease, Inflammatory, Hypertensive heart disease, Ischemic, Rheumatic heart disease, Acute heart failure and Heart transplantation.

Hypertension and tachycardia
Structural heart disease
Transient ischemic attack
Risk factor for fatal and nonfatal cardiovascular disease
Cardiovascular medicine research
New theories of diagnosis of the blood vessels
Cardiometabolic diseases management
Cardiac rehabilitation
Cardiac catheterizations, and electrophysiology studies

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 8: Evaluation of Hypertension

The evaluation of patients with resistant hypertension should be directed toward confirming true treatment resistance; identification of causes contributing to treatment resistance, including secondary causes of hypertension; and documentation of target-organ damage. Accurate assessment of treatment adherence and use of good blood pressure measurement technique is required to exclude pseudo resistance. In most cases, treatment resistance is multifactorial in etiology with obesity, excessive dietary sodium intake, obstructive sleep apnea, and CKD being particularly common factors.

Target-organ damage such as retinopathy, CKD, and LVH supports a diagnosis of poorly controlled hypertension and in the case of CKD will influence treatment in terms of classes of agents selected as well as establishing a blood pressure goal of <130/80 mm Hg. Most patients who present with elevated blood pressure (BP) will have essential (idiopathic) hypertension; extensive laboratory evaluation for secondary causes in these patients is low-yield and cost-prohibitive. However, identification of a secondary cause may often lead to a cure of the elevated BP or to a decrease in the number and/or doses of antihypertensive agents and a reduction in the long-term cardiovascular risks of hypertension.

ELISA for AAAR and cardiac myosin
Laboratory tests for the investigation
Endocrine or hormonal regulation of BP
Diagnostic imaging modalities
Interventional cardiology
Teleradiology

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 9: Causative Factors, Risk Assessment and Complications

High blood pressure has several causative factors like age, race, case history and obesity, not being physically active, overwhelming tobacco, an excessive amount of salt (sodium) in diet, deficient Vitamin D in diet, drinking an excessive amount of alcohol, stress and bound chronic conditions. Though high pressure is commonest in adults, youngsters are also in danger, too. For a few youngsters, high pressure is caused by issues with the kidneys or heart except for a growing variety of youngsters, poor fashion habits, like an unhealthy diet, fleshiness, physiological condition and lack of exercise contributes to high pressure.

Certain diseases and medications are specific causes of high pressure. Cardiovascular disease represents the leading reason for morbidity and mortality in Western countries, and hypertension-related vessel events have an effect on regarding 37 million individuals annually, worldwide. During this perspective, hypertensive patients are at hyperbolic risk to expertise vessel events throughout life-long period, and treatment of high pressure represents one among the foremost effective ways to cut back cardiovascular risk.

Obesity and weight management
Non-steroidal anti-inflammatory drugs
Not being physically active and using tobacco.
Controllable risk factors
Uncontrollable risk factors
Medical risk factors
Global cardiovascular risk assessment
Multiple risk management

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 10: Diagnosis and Pathophysiology of Hypertension

Hypertension, or high blood pressure, is the leading risk factor associated with death in the world but is largely asymptomatic and often undetected in patients. Hypertension is typically asymptomatic and only detected through opportunistic screening. Once hypertension has been diagnosed, further tests should be conducted, including urine testing, blood tests, an eye examination and a 12-lead electrocardiogram (ECG). Primary hypertension, in which no specific cause is found, affects 95% of patients. Blood pressure is expressed in terms of systolic blood pressure (higher reading), which reflects the blood pressure when the heart is contracted (systole), and diastolic blood pressure (lower reading), which reflects the blood pressure during relaxation (diastole).

Hypertension can be diagnosed when either systolic pressure, diastolic pressure, or both are raised. Blood pressure is determined by the cardiac output balanced against systemic vascular resistance. The process of maintaining blood pressure is complex, and involves numerous physiological mechanisms, including arterial baroreceptors, the renin–angiotensin–aldosterone system, atrial natriuretic peptide, endothelin’s, and mineralocorticoid and glucocorticoid steroids.

Renin angiotensin aldosterone system
Sodium /potassium ratio hypothesis of essential hypertension
Echocardiogram
Endoscopy
Polysomnogram
Endothelial dysfunction
Vascular damage in hypertension

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 11: Anti- Hypertensive Medications

There is no specific treatment, but is monitored closely to rapidly identify pre-eclampsia and its life-threatening complications. Drug treatment options are limited, as many antihypertensive may negatively affect the fetus. Methyldopa, hydralazine, and labetalol are most commonly used for severe pregnancy hypertension.

Drug treatments are available too for Hypertension. Optimal blood pressure control plays an essential role in the therapeutic management of RVHT. However, aggressive control of other risk factors for atherosclerosis also is crucial. Cessation of smoking is important for its positive impact on the cardiovascular risk profile in patients with hypertension. Similarly, antidyslipidemic therapy for those patients with hyperlipidemia likely provides benefit in atherosclerotic RVHT.

Diuretics
Calcium channel blockers
ACE Inhibitors
Angiotensin II receptor antagonists
Benzodiazepines
Vasodilation

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 12: Hypertension Therapy Devices

Hypertension Reduction Therapy Devices externally stimulate carotid baroreceptors, which are located within the carotid sinus in the neck, using our hand-held therapy device with our patented cold tip. Cold temperature stimulation of the baroreceptors, at a precise temperature and duration, results in modulating the autonomic nervous system, stimulating the parasympathetic nervous system, and lowering the sympathetic drive, causing vasodilation and lowering of the heart rate. The sum of these actions results in immediate lowering of blood pressure.

The fundamental goal of treatment should be the prevention of the important endpoints of hypertension, such as heart attack, stroke and heart failure. Patient age, associated clinical conditions and end-organ damage also play a part in determining dosage and type of medication administered. The several classes of antihypertensive differ in side effect profiles, ability to prevent endpoints, and cost. The choice of more expensive agents, where cheaper ones would be equally effective, may have negative impacts on national healthcare budgets. As of 2018, the best available evidence favors the thiazide diuretics as the first-line treatment of choice for high blood pressure when drugs are necessary.

Blood pressure measuring devices
Novel non-pharmacological approaches
Baroreceptor activation therapy
Transdermal therapy of hypertension
Ambulatory blood pressure monitoring
Substantial placebo effect of device therapy
Baroreflex activation therapy
Carotid body ablation
Renal denervation
Central iliac arterio-venous anastomosis
Renal replacement therapy

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 13: Diet and Lifestyle in Hypertension Management

Changes in single nutrients—such as lowering sodium—have been the primary focus on dietary interventions to prevent and treat hypertension. However, weight reduction, adopting the DASH eating pattern (which emphasizes fruits, vegetables, low-fat dairy foods, whole grains, poultry, fish and nuts and is low in saturated fat, total fat and cholesterol) and engaging in physical activity have potentially the same or greater effect on managing hypertension as sodium reduction.

The prevalence of hypertension is high and increasing worldwide. Drug therapy is effective, but for both "prehypertensive" and treated hypertensive patients, lifestyle changes are also important. Dietary modification is a key part of these changes, although skepticism about the role of diet in determining blood pressure has slowed implementation of the available guidelines. However, there is now a large body of evidence supporting a role for dietary salt, potassium, alcohol, and body mass in determining blood pressure.

Studies such as PREMIER have shown that salt restriction (<6 g/d), alcohol moderation (<2U/d in men and <1U/d in women), weight loss (if BMI>25), exercise, and a DASH (Dietary Approaches to Stop Hypertension) diet (supplying 20-30 m.mol/d of potassium) can achieve decreases in systolic blood pressure of approximately 10 to 15 mm Hg when applied together. Of the dietary changes, salt intake remains the most amenable to change. But we must further reduce salt in processed food if it is to be part of a wider strategy to lower blood pressure in the general population. Nevertheless, the message to patients must be that dietary changes made within a concerted alteration in lifestyle can have a very significant impact on their blood pressure.

Health professionals can assist clients to combine two or more lifestyle modifications to achieve even greater results.

Smoking cessation
Salt sensitivity and resistance
Dietary potassium
Lowering blood pressure
Maintenance therapy and reassessment
Resources for promoting lifestyle management to patients
Incorporating patient-centered lifestyle modification

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 14: Nursing Management of Hypertension

Nursing service administration is a coordinated activity, which provides all the facilities necessary for the rendering of nursing service to clients. Nursing service administration is the system of activities directed toward the nursing care of clients, and includes Nursing Leadership and Management the establishment of over-all goals and policies within the aims of the health agency and provision of organization, personnel, and facilities to accomplish this goals in the most effective and economical manner through cooperative efforts of all members of the staff, coordinating the service with other departments of the institution.

Nursing service administration is the provision for continuous individual, group and community service, including whatever is necessary. In addressing the factors, which determine health, and to bring them back to self-directive activity towards their own health. The subsidiary objectives of this role are the professional activities of administration, including human relations, communications, teaching, research, and personal development, designed to further the primary objective-the optimum nursing care of patients. In this lecture note management and administration are used interchangeably. Threshold for Initiation of Treatment and Target Values, Assessment and Development of a Lifestyle Treatment plans are the major criteria for nursing management.

Opportunity to assess BP detection
Educate clients on their target BP
Importance of achieving and maintaining target
Frequent error in clinic-based BP assessment
Patient preparation and posture
Recommended technique for measuring blood pressure
Threshold for Initiation of treatment and target values
Assessment and development of a lifestyle treatment plan
Impact of lifestyle therapies on BP in hypertensive
Monitoring and follow up with the health care team
Medications and adherence

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 15 : Advanced Treatment Approaches

Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension, or high blood pressure, is dangerous because it can lead to strokes, heart attacks, heart failure, or kidney disease. The goal of hypertension treatment is to lower high blood pressure and protect important organs, like the brain, heart, and kidneys from damage. Treatment for hypertension has been associated with reductions in stroke (reduced an average of 35%-40%), heart attack (20%-25%), and heart failure (more than 50%), according to research.

Because hypertension rarely causes specific symptoms, it is not identified until an individual’s blood pressure is measured by a physician or it causes a catastrophic complication such as stroke or heart attack. Accurate diagnosisby blood pressure measurement is essential. Many advanced treatment approaches and medications have been established for the treatment and management of hypertension that may describe this session.

Trans catheter renal denervation
Neprilysin /neutral endopeptidase (NEP) inhibition
Non-viral gene therapy
Stem cell therapy
Invasive therapy

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 16: Clinical Trials and Case Reports

To fully appreciate the complexity and challenges in interpreting hypertension trials, it is informative to review their evolution. The prospective, randomized, clinical trial has been the foundation for evaluating the effectiveness of blood pressure-lowering drugs. The duration of clinical trials rarely exceeds five years, and trials focus on so-called “hard end points”—notably, all-cause mortality and/or cause specific morbidity and mortality due to CVD, usually coronary heart disease (CHD) and/or stroke, but more recently heart failure (HF) as well.

The early clinical trials had the advantage of being able to compare “active therapy” with placebo and usually included patients with more severe hypertension, as compared with modern trials. Consequently, they generated more end points and had sufficient power to be conducted on a smaller scale than modern trials high blood pressure is often called a "silent disease" because people usually don't know they have it; there may be no outward symptoms or a sign, so monitoring the blood pressure is critical. Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension treatment comes in many forms -- from lifestyle changes to medication.

Integrating lifestyle advice into clinical management
Clinical practice guidelines for the management of overweight and obesity
Data management and statistical analysis and data validation processes
Meta-analysis of blood pressure-lowering drug trials
Reporting blood pressure parameters in clinical trails
Surrogate or intermediate disease markers
Assessment of overall cardiovascular risk in hypertensive patients
Primary biliary cirrhosis

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Track 17: Cardiologists Training and Education

The mission and education of the cardiologists training is that to reduce the burden of cardiovascular disease in Europe, education is an important mean to achieve its mission. At ESC, education is the transfer of knowledge together with assessment to ascertain the breadth of knowledge and skills has been retained.

In general cardiology and sub-specialties, all educational activities are mapped out on curricula. Increasingly, educational activities are organized into educational tracks leading to certification and recertification programmers (in sub-specialties of cardiology currently). Ultimately, the aim is to cater for ESC members’ lifelong learning. All ESC educational programmers are submitted to the EBAC for accreditation for development of future educational programmes.

National health and medical council
patient lifestyle modification
Counseling and assessment with hypertension
Monitoring antihypertensive drug treatment
Absolute CVD risk assessment
Clinical tuberculosis & epidemiology research
Chronic respiratory diseases research
Cardiac monitoring with emergency department

Related Conferences:

20th European Cardiology Conferences, October 16-18, 2017 Budapest, Hungary, 22nd World Cardiology Conferences, December 11-12, 2017 Rome, Italy, 23rd European Heart Failure Congress, February 19-21, 2018 Paris, France, 3rd Cardiovascular Conferences, July 05-06, 2018, Berlin, Germany, 3rd World Heart Congress, April 19-20, 2018, Amsterdam, Netherlands, 26th Cardiology Case Reports Conferences, July 05-06, 2018, Berlin, Germany, Heart Surgery & Cardiology Conferences, September 21-22, 2017 San Antonio, Texas, USA; Heart Conferences, December 04-05, 2017 Dallas, Texas, USA, 25th Euro Congress on Pediatric Heart Disease and Health, August 13-14, 2018 Dublin, Ireland; PCR London Valves 2017, September 24-26, 2017, 13th Asian-Pacific Congress of Hypertension, October 15-18, 2017, 4th International 4 Corners of Cardiology Meeting 2018, February 09-10. 2018, National Cardiology Conferences, USA EHRA Congress 2018, March 18-20, 2018, Barcelona, Spain, Frontiers in Cardiovascular Biology2018, April 20-22, 2018, Heart Failure 2018, May 26-29, 2018, Euro Heart Care 2018, June 07-09, HKSTENT-CICF 2018, Hong Kong.

Related Societies:

America: American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Diabetes Association, American Stroke Association, Inter-American Society of Hypertension, Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association, Congenital Cardiac Anaesthesia Society, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada

Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Emirates Cardiac Society

Asia-Pacific: Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation , High Blood Pressure Research Council of Australia, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society, Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation

Market analysis

Cardiology Meetings is glad to invite you to the upcoming 4th International Conference on Hypertension & Healthcare planned to be held in the beautiful Zurich City, Switzerland during September 10-12, 2018. The conference emphasizes the theme “Control Hypertension: Add life to Longevity”. Focusing on the latest ideas and advances for hypertension treatment and management. Hypertension 2018 welcomes the innovative strategies in the area of hypertension research and also proposes a unique opportunity for the explorers from all over the world to gather, share and perceive new scientific interactions upon the various perceptions of hypertension.

Conference Series Ltd organizes 600+ Conferences Every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Conference Highlights:

Hypertension
High Blood Pressure and Kidney Diseases
Pulmonary Hypertension
Gestational Hypertension
Hypertension and Stroke
Hypertension and Diabetes
Hypertensive Heart Disease
Evaluation of Hypertension
Causative Factors, Risk Assessment and Complications
Diagnosis and Pathophysiology of Hypertension
Anti- Hypertensive Medications
Hypertension Therapy Devices
Diet and Lifestyle in Hypertension Management
Nursing Management of Hypertension
Advanced Treatment Approaches
Clinical Trials and Case Reports
Cardiologists training and education

Important and scope:

Hypertension is a major risk factor for cardiovascular diseases, cerebrovascular events and ischaemic heart diseases, so is therefore one of the most important preventable causes of premature morbidity and mortality in developed and developing countries. It is often symptomless, so screening is vital before damage is done. Many surveys continue to show that hypertension remains underdiagnosed, undertreated and poorly controlled. Overall, the prevalence of hypertension (at least ≥140/90 mm Hg or on treatment) in those aged over 35 was observed to be 32% in men and 27% in women.

A prospective survey of patients in 20th century electrocardiography, preventive cardiology and the Framingham Study, lipid hypotheses and atherosclerosis, coronary care units, thrombolytic therapy, cardiac catheterization and coronary angiography, open-heart surgery, automatic implantable cardiac defibrillators, and coronary angioplasty. In hypertension, different changes made to the understand the basic levels of blood pressure and in the development of new diagnostic and therapeutic techniques.

Hypertension 2018 is an international platform for presenting research about Hypertension and related concepts, sharing alternative ideas about the severe cardiovascular risk factor, contributing to the dissemination of information about the trouble for the welfare of the society.

Why Zurich:

Zurich ability to conduct independent research is a decisive factor in boosting nation’s competitiveness. A place for conducting good research for hypertension and cardiovascular research with having institutes like European organization for nuclear research, university of Zurich, Advanced Medical Research Centres, and many more centres will come in handy. The important research conducted in Zurich is Clinical Research which includes pre-clinical and Clinical Trials. With 5% of GNP, Zurich is unique in their science and the availability of raw materials to industrial companies offers them excellent research opportunities.

Members Associated with Hypertension:

There are 582 Cardiology Specialists near and 1250 Cardiology Specialists in Switzerland and 42000 cardiology specialists in world wide.

Societies Associated with Hypertension:

Swiss society of cardiology
The European Society Heart and Lung Transplantation
CFA Society Switzerland
Swedish Society of Cardiology
The Union of Vascular Societies of Switzerland UVSS
European Stroke Organisation (ESO)
Swiss Federation of Clinical Neuro-Societies
World Federation of Neuroradiological Societies

Hospitals Associated with Hypertension:

Zurich Hospitals:

University Hospital of Zürich
Municipal Hospital Triemli
Klinik Hirslanden
Stadtspital Waid
Department of infectious diseases and hospital epidemiology
PET CT MR Centre, University Hospital Zurich
Children's Hospital Zurich - Eleonore Foundation
Schulthess Clinic
Klinik Pyramide am See
Psychiatrist Universitätsklinik Zürich
UniversitätsSpital Zürich Klinik fur Gynäkologie
Psychiatrist Universitätsklinik Zürich,
Bal grist University Hospital
Ambulant Augenchirurgie Zürich AG
Medgate Health Centre

Switzerland Hospitals:

University of Basel
University of Bern
University of Fribourg
University of Geneva
University of Neuchâtel
University of Lausanne
University of Lucerne
University of Lugano
University of St. Gallen
University of Zurich
Swiss Federal Institute of Technology Lausanne (EPFL)
Swiss Federal Institute of Technology Zurich (ETH)
Bern University of Applied Sciences
University of Applied Sciences of Northwest Switzerland
University of Applied Sciences of Eastern Switzerland
Interactionalists College of Therapeutic Education
Swiss University of Applied Sciences Rorschach SHLR
Business schools in Switzerland
Private schools in Switzerland

Globe:

North-western Memorial Hospital
Hospitals of the University of Pennsylvania-Penn Presbyterian
Mount Sinai Hospital
University of Michigan Hospitals and Health Centers
Duke University Hospital
Brigham and Women's Hospital
Barnes-Jewish Hospital
UCLA Medical Center
Stanford Health Care-Stanford Hospital
Heart Hospital Baylor Plano
Houston Methodist Hospital
Loyola University Medical Center
NYU Langone Medical Center
UPMC Presbyterian Shadyside
Scripps La Jolla Hospitals
Ohio State University Wexner Medical Center
UCSF Medical Center
Sentara Norfolk General Hospital-Sentara Heart Hospital
Texas Heart Institute at Baylor St. Luke's Medical Center
Beaumont Hospital-Royal Oak
Minneapolis Heart Institute at Abbott Northwestern Hospital
Vanderbilt University Medical Center
Memorial Hermann-Texas Medical Center
University of Alabama at Birmingham Hospital
University of Colorado Hospital
St. Francis Hospital

Universities Associated with Hypertension:

Zz Zurich Universities:

Swiss Federal Institute of Technology Zurich
Kalaidos Fachhochschule
University of Zurich
Zurich University of Applied Sciences
University of Zurich
Zurich Heart House
Dr. med. Renata Fatio, Fachärztin FMH fur Innere Medizin u. Cardiology
University Hospital of Zürich

Switzerland Universities:

University of Basel
University of Bern
University of Fribourg
University of Geneva
University of Neuchâtel
University of Lausanne
University of Lucerne
University of Lugano
University of St. Gallen
University of Zurich
Swiss Federal Institute of Technology Lausanne (EPFL)
Swiss Federal Institute of Technology Zurich (ETH)
Bern University of Applied Sciences
University of Applied Sciences of Northwest Switzerland
University of Applied Sciences of Eastern Switzerland
Interactionalists College of Therapeutic Education
Swiss University of Applied Sciences Rorschach SHLR
Business schools in Switzerland
Private schools in Switzerland

Worldwide:

Harvard University
University of Oxford
University of Cambridge
Johns Hopkins University
Stanford University
Yale University
University of California, Los Angeles
Imperial College London
University of Melbourne
Karolinska Institute
University of Geneva
University of Basel,
University of Bern,
University of St Gallen (HSG)
University de Fribourg
University of St. Gallen
Dominican College of Philosophy and Theology
First Nations University of Canada
Royal Military College of Canada
University Canada West
Aga Khan University
Birkbeck College, University of London
Brescia College
British College of Osteopathic Medicine
British Institute in Paris, University of London
Brunel University Uxbridge
Camberwell College of Arts
Central Saint Martin’s College of Art & Design
Chelsea College of Art and Design
City University
European School of Economics
Goldsmiths College, University of London
Heythrop College, University of London
Huron University College
Imperial College School of Medicine
Institute of Historical Research, University of London
Institute of Advanced Legal Studies, University of London
Institute of Classical Studies, University of London
American College of Greece
University of Central Greece
Asia University
Beijing New Asia University
Eastern Asia University
Engineering Faculty of Asian University
Eurasia International University

Industries Associated with Hypertension:

Johnson & Johnson pharmaceutical manufacturer company
Novartis pharmaceutical company ltd.
Roche pharmaceutical company
Sanofi pharmaceutical company
Merck pharmaceutical company
AstraZeneca pharmaceutical company
Gilead Sciences and health care

Global Market at a Glimpse:

High blood pressure or hypertension is the most important risk factor for cardiovascular disease. In over 90% of cases there may be no identifiable cause of hypertension, in which case the condition is known as essential hypertension. The remaining 10% of cases, hypertension may be secondary in nature as a consequence of another medical problem, such as kidney disorders, adrenal tumours, or some drugs.

The Global Blood Pressure Monitoring Devices Market was valued at USD 2,086.6 Mn in 2017, and is expected to reach USD 3,482.4 Mn by 2025, expanding at a CAGR of 6.7% from 2017-2025.Rising prevalence of heart disorders, increasing obese population and growing geriatric population are the major factors driving the global market for blood pressure monitoring devices. North America command the biggest regional market, accounting for the market share of over half-hour in 2015, a to dominate the global blood pressure monitoring devices market during the forecast period of 2016 - 2022. Rising geriatric population in the region, susceptible for heart diseases, and higher spending for home healthcare segment together drive the North America blood pressure monitoring devices market. Asia Pacific is expected to grow at a highest growth rate during the focus period, due to developing healthcare infrastructure, rising awareness regarding better health among the masses and rising number of regional device manufactures driving the blood pressure monitoring devices market in the region.

Among the device varieties, machine-controlled pressure level monitors is that the most generally used device in terms of revenue. Portability, ease in handling, high accuracy and value for money are the major factors driving automated blood pressure monitors market. Ambulatory blood pressure monitors is anticipated to be the fastest growing segment in the device type segment, due to the effective use in the diagnosis of white-coat hypertension and masked hypertension. Moreover, introduction of high finish ambulant pressure level monitors by leading corporations would any drive the market.

Products manufactured by the industry related Hypertension:

My Lab™ Gamma’.
Multipurpose ultrasound imaging smart portable ultrasound system
Ultrasound transducer
Micro convex ultrasound
Pencil probe ultrasound
Transoesophageal ultrasound transducer
FUJIFILM Medical Systems U.S.A., Inc.- latest version of Synapse Cardiovascular 6.0.
Synapse 3D
HAUSMANN INDUSTRIES, INC.-Echo-Scan
Kontron

Kontron's Medical Computers enable sustainable and viable medical solutions for several applications.

Fund Allotment to Hypertension Research:

The NIH (National Institute of Health) Funding Opportunity Announcement (FOA), funded by the Patient-Cantered Outcomes Research Institute (PCORI), funds up to two new patient-centred comparative effectiveness clinical trials, with the goal of comparing alternative, evidence-based ways to reduce inadequate control of hypertension and disparities in outcomes among high-risk populations, including racial/ethnic minority groups, patients with low socioeconomic status (SES), and individuals residing in rural geographical areas with an above average lifetime risk of cardiovascular disease (CVD). This initiative is supported by the Hypertension Disparities Reduction Program Partnership (HDRPP), a research partnership between NHLBI, NINDS and PCORI, with funds provided by PCORI to the NIH.

The fund allotment granted by the NIH is raised up to $21,500,000 worldwide for supporting research works associated with the advances in treatment and management of Hypertension

Statistics of Physicians, Researchers and Academicians working on Hypertension:

The estimated statistics of the number of physicians, academicians and researchers working upon the advancement in the treatment and management of hypertension are as described in the pie chart here in.

Past Conference Report

Hypertension 2017

Thanks to all of our wonderful speakers, conference attendees of Hypertension 2017 Conference were our best ever!

2nd International Conference on Hypertension & Healthcare was held during September 11-13, 2017 Amsterdam, Netherlands with the theme “New insights in diagnosis and management for hypertension”. Benevolent response and active participation from the Scientists, Doctors, Professors, Pharmaceutical Industries, Healthcare Industries, Researchers and Students from the fields of cardiology and healthcare who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks: Hypertension, Hypertension & Obesity, Renal Hypertension, Pulmonary Hypertension, Gestational Hypertension, Hypertension & Stroke, Causative Factors and Risk Assessment, Diagnosis and Pathophysiology of Hypertension, Pharmacologic and Other Treatments for Hypertension, Diet and Lifestyle in Hypertension Management, Hypertension Epidemiology, Advanced Treatment Approaches, Clinical Case Reports

Hypertension 2017 Organizing Committee would like to thank the Moderators of the conference – Dr. Fabiola B Sozzi, University of Milan, Italy and A.J. van Ballegooijen, VU University, The Netherlands

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr.Michiel Voskuil from Universitair Medisch Centrum Utrecht, The Netherlands and Dr. Attila Kardos from Milton Keynes University Hospital, UK and Igor I Tulevski from Cardiologie Centra Nederland, The Netherlands

The highlights of the meeting were the eponymous lectures, delivered by:

Dr. Fabiola B Sozzi, University of Milan, Italy
Hossein Tabriziani, Loma Linda University, USA
Valéria Paula S. Fazan, University of Sao Paulo, Brazil
Nilda Gladys Espinola-Zavaleta, National Institute of Cardiology Ignacio Chavez, Mexico
Patricia Hidalgo M, San Ignacio-Pontificia Universidad Javeriana, Colombia
Alan Fleming, Optos, UK
Louis Peeters, Utrecht University, The Netherlands
Marc Spaanderman, Maastricht University, The Netherlands
Johannes J. (Hans) Duvekot, Erasmus University, The Netherlands
Peter de Leeuw, Maastricht University, The Netherlands
Faezeh Sahbaeiroy, Iran
Bum Ju Lee, Korea Institute of Oriental Medicine, Republic of Korea
A.J. van Ballegooijen, VU University, The Netherlands
Fatemeh Esfarjani, Shahid Beheshti University of Medical Sciences, Iran
Amar Mohanrao Taksande, Jawaharlal Nehru Medical College, India
Soha M Abd El Dayem, National Research Centre, Egypt
Ahmed A Battah, Cairo University, Egypt

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums at Hypertension 2017. We sincerely thank the Organizing Committee Members, Editorial Board Members of International Journals, Participants, Attendees and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, we would like to announce the commencement of the 4th International Conference on Hypertension & Healthcare during September 10-12, 2018 at Zurich, Switzerland.

4th International Conference on Hypertension & Healthcare September 10-12, 2018 Zurich, Switzerland

About Conference

Sessions

Market analysis

Past Conference Report

Tin nổi bật